424 related articles for article (PubMed ID: 2406808)
21. [Pulmonary involvement in systemic sclerosis].
Ioanăş M
Pneumologia; 2002; 51(3):230-3. PubMed ID: 12602096
[No Abstract] [Full Text] [Related]
22. [Various aspects of the differential diagnosis of a pulmonary syndrome in systemic scleroderma and chronic aspecific lung diseases].
Doroshenko IuA; Bagirova VV; Savinova NA
Ter Arkh; 1987; 59(4):92-7. PubMed ID: 3590012
[TBL] [Abstract][Full Text] [Related]
23. CCL18 as an indicator of pulmonary fibrotic activity in idiopathic interstitial pneumonias and systemic sclerosis.
Prasse A; Pechkovsky DV; Toews GB; Schäfer M; Eggeling S; Ludwig C; Germann M; Kollert F; Zissel G; Müller-Quernheim J
Arthritis Rheum; 2007 May; 56(5):1685-93. PubMed ID: 17469163
[TBL] [Abstract][Full Text] [Related]
24. Static lung mechanics in patients of progressive systemic sclerosis without obvious pulmonary involvement.
Gupta D; Aggarwal AN; Sud A; Jindal SK
Indian J Chest Dis Allied Sci; 2001; 43(2):97-101. PubMed ID: 11529415
[TBL] [Abstract][Full Text] [Related]
25. The lung megakaryocytes and pulmonary fibrosis in systemic sclerosis.
Thachil J
Med Hypotheses; 2009 Mar; 72(3):291-3. PubMed ID: 19036527
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms of Disease: leukotrienes and lipoxins in scleroderma lung disease--insights and potential therapeutic implications.
Kowal-Bielecka O; Kowal K; Distler O; Gay S
Nat Clin Pract Rheumatol; 2007 Jan; 3(1):43-51. PubMed ID: 17203008
[TBL] [Abstract][Full Text] [Related]
27. [The correlations of respiratory function tests, chest roentgenographic manifestations and respiratory symptoms in the patients with systemic sclerosis, using a scoring-method for symptoms].
Kikuchi K; Igarashi A; Ishibashi Y; Inokuma S; Takehara K
Nihon Hifuka Gakkai Zasshi; 1990 May; 100(6):695-700. PubMed ID: 2214236
[TBL] [Abstract][Full Text] [Related]
28. The presence of Sjögren's syndrome is a major determinant of the pattern of interstitial lung disease in scleroderma and other connective tissue diseases.
Breit SN; Cairns D; Szentirmay A; Callaghan T; Murray D; Wacher T; Gibson PG; Marks G; Bryant DH; Yeates M
J Rheumatol; 1989 Aug; 16(8):1043-9. PubMed ID: 2585401
[TBL] [Abstract][Full Text] [Related]
29. A pilot study of intermittent intravenous cyclophosphamide for the treatment of systemic sclerosis associated lung disease.
Várai G; Earle L; Jimenez SA; Steiner RM; Varga J
J Rheumatol; 1998 Jul; 25(7):1325-9. PubMed ID: 9676764
[TBL] [Abstract][Full Text] [Related]
30. Arterial and interstitial remodelling processes in non-specific interstitial pneumonia: systemic sclerosis versus idiopathic.
de Carvalho EF; Parra ER; de Souza R; A'b Saber AM; Machado Jde C; Capelozzi VL
Histopathology; 2008 Aug; 53(2):195-204. PubMed ID: 18752502
[TBL] [Abstract][Full Text] [Related]
31. Different expression of endothelin in the bronchoalveolar lavage in patients with pulmonary diseases.
Reichenberger F; Schauer J; Kellner K; Sack U; Stiehl P; Winkler J
Lung; 2001; 179(3):163-74. PubMed ID: 11891606
[TBL] [Abstract][Full Text] [Related]
32. [Proceedings: Pathology and clinical aspects of interstitial lung diseases].
Otto H
Med Klin; 1975 Jun; 70(23):996-7. PubMed ID: 1207626
[No Abstract] [Full Text] [Related]
33. Lung disease associated with progressive systemic sclerosis. Assessment of interlobar variation by bronchoalveolar lavage and comparison with noninvasive evaluation of disease activity.
Miller KS; Smith EA; Kinsella M; Schabel SI; Silver RM
Am Rev Respir Dis; 1990 Feb; 141(2):301-6. PubMed ID: 2301848
[TBL] [Abstract][Full Text] [Related]
34. The manifestations of vasculopathy in systemic sclerosis and its evidence-based therapy.
Strange G; Nash P
Int J Rheum Dis; 2009 Sep; 12(3):192-206. PubMed ID: 20374346
[TBL] [Abstract][Full Text] [Related]
35. Pulmonary function in patients with systemic sclerosis.
Spagnolatti L; Zoia MC; Volpini E; Convertino G; Fulgoni P; Corsico A; Vitulo P; Cerveri I
Monaldi Arch Chest Dis; 1997 Feb; 52(1):4-8. PubMed ID: 9151512
[TBL] [Abstract][Full Text] [Related]
36. Rapid onset of lung involvement in progressive systemic sclerosis.
Bettmann MA; Kantrowitz F
Chest; 1979 Apr; 75(4):509-10. PubMed ID: 446143
[TBL] [Abstract][Full Text] [Related]
37. [Pulmonary involvement in systemic scleroderma. Part I. Chronic fibrosing interstitial lung disease].
Marie I; Lévesque H; Dominique S; Hatron PY; Michon-Pasturel U; Remy-Jardin M; Courtois H
Rev Med Interne; 1999 Nov; 20(11):1004-16. PubMed ID: 10586439
[TBL] [Abstract][Full Text] [Related]
38. Lung involvement in systemic sclerosis (scleroderma): relation to classification based on extent of skin involvement or autoantibody status.
Kane GC; Varga J; Conant EF; Spirn PW; Jimenez S; Fish JE
Respir Med; 1996 Apr; 90(4):223-30. PubMed ID: 8736656
[TBL] [Abstract][Full Text] [Related]
39. Pulmonary scleroderma.
Weaver AL; Divertie MB; Titus JL
Dis Chest; 1968 Dec; 54(6):490-8. PubMed ID: 5722767
[No Abstract] [Full Text] [Related]
40. Pulmonary manifestations of collagen diseases.
Gómez Carrera L; Bonilla Hernan G
Arch Bronconeumol; 2013 Jun; 49(6):249-60. PubMed ID: 23683373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]